Recombinant Renibacterium salmoninarum Elongation factor Tu (tuf)

Shipped with Ice Packs
In Stock

Description

Elongation Factor Tu (EF-Tu): Canonical and Moonlighting Functions

EF-Tu is a highly conserved GTP-binding protein critical for bacterial translation, facilitating aminoacyl-tRNA delivery to ribosomes . Beyond its core role, EF-Tu exhibits moonlighting functions in pathogens, including:

  • Adhesion: Binding to extracellular matrix components (e.g., collagen, fibronectin) for host cell attachment .

  • Immune modulation: Interacting with host receptors to evade recognition or suppress immune responses .

  • Biofilm formation: Contributing to structural integrity in biofilms (e.g., Gallibacterium anatis) .

EF-Tu in Renibacterium salmoninarum: Current Knowledge Gaps

While R. salmoninarum is a major salmonid pathogen, its EF-Tu has not been extensively characterized. Key observations include:

AspectDetailsSources
Gene duplicationR. salmoninarum lacks reported tuf duplication, unlike some gram-negative bacteria .
Protein expressionEF-Tu is predicted to be cytoplasmic, with no signal peptides for secretion .
Virulence associationNo direct evidence linking R. salmoninarum EF-Tu to pathogenesis; MSA remains the primary antigen .

Molecular Insights into R. salmoninarum

Although EF-Tu research is limited, studies on R. salmoninarum highlight other virulence factors:

Virulence FactorFunctionRelevance to EF-Tu
MSAMajor soluble antigen; immunodominant, extracellular protein .Duplicates msa1/msa2 for high expression .
Iron acquisitionProteins for iron uptake, critical for intracellular survival .Distinct from EF-Tu’s roles.
Secretion pathwaysSec/SPI, Lipo/SPII, and Tat/SPI systems identified, but EF-Tu lacks signal peptides .Limits extracellular EF-Tu exposure.

Research Opportunities for Recombinant R. salmoninarum EF-Tu

Future studies could explore:

  1. Structural analysis: Identify surface-exposed motifs (e.g., SLiMs) enabling moonlighting functions .

  2. Vaccine development: Test rEF-Tu as a subunit vaccine, leveraging its immunogenic potential in other pathogens .

  3. Gene knockout models: Assess EF-Tu’s role in translation and pathogenesis via tuf deletion mutants.

Product Specs

Form
Lyophilized powder. We will ship the format we have in stock. If you have special format requirements, please note them when ordering.
Lead Time
Delivery times vary by purchase method and location. Consult your local distributor for specific delivery times. All proteins are shipped with blue ice packs by default. Contact us in advance for dry ice shipping (extra fees apply).
Notes
Avoid repeated freeze-thaw cycles. Working aliquots are stable at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer components, storage temperature, and protein stability. Liquid form is generally stable for 6 months at -20°C/-80°C. Lyophilized form is generally stable for 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon arrival. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during manufacturing. If you require a specific tag, please inform us and we will prioritize its development.
Synonyms
tuf; RSal33209_2171Elongation factor Tu; EF-Tu
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-396
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Renibacterium salmoninarum (strain ATCC 33209 / DSM 20767 / JCM 11484 / NBRC 15589 / NCIMB 2235)
Target Names
tuf
Target Protein Sequence
MAKAKFERTK PHVNIGTIGH VDHGKTTLTA AISKVLYDKY PTLNEQRDFA SIDSAPEEKQ RGITINISHV EYQTEKRHYA HVDAPGHADY IKNMITGAAQ MDGAILVVAA TDGPMAQTRE HVLLARQVGV PYLLVALNKS DMVEDEELLD LVEMEVRELL SSQEFDGDNA PVVRVSGLKA LEGDPQWVKS VEDLMEAVDE SVPDPIRDKD KPFLMPIEDV FTITGRGTVV TGRAERGTLA INSEVEIVGI RPIQKTTVTG IEMFHKQLDE AWAGENCGLL LRGIKREDVE RGQVVVKPGS ITPHTDFEAN VYILSKDEGG RHNPFYSNYR PQFYFRTTDV TGVITLPEGT EMVMPGDNTE MTVALIQPIA MEDGLGFAIR EGGRTVGSGR VTKIIK
Uniprot No.

Target Background

Function
This protein promotes GTP-dependent binding of aminoacyl-tRNA to the ribosomal A-site during protein biosynthesis.
Database Links
Protein Families
TRAFAC class translation factor GTPase superfamily, Classic translation factor GTPase family, EF-Tu/EF-1A subfamily
Subcellular Location
Cytoplasm.

Q&A

Experimental Design for Studying Recombinant Renibacterium salmoninarum Elongation Factor Tu (tuf)

Q: What experimental design strategies can be employed to study the recombinant elongation factor Tu (tuf) in Renibacterium salmoninarum?

A: To study recombinant Renibacterium salmoninarum elongation factor Tu (tuf), researchers can employ several experimental design strategies:

  • Cloning and Expression: Clone the tuf gene into an appropriate expression vector and transform it into a suitable host organism, such as Escherichia coli, to produce recombinant protein.

  • Protein Purification: Use techniques like affinity chromatography to purify the recombinant protein for further analysis.

  • Functional Assays: Conduct assays to assess the protein's role in protein synthesis and its potential as a vaccine candidate or diagnostic marker.

Data Analysis and Contradiction Resolution

Q: How can researchers resolve data contradictions when analyzing the expression levels of recombinant Renibacterium salmoninarum elongation factor Tu (tuf) in different hosts?

A: Resolving data contradictions involves several steps:

  • Replication: Repeat experiments to ensure consistency.

  • Normalization: Normalize data using appropriate controls to account for variations.

  • Statistical Analysis: Use statistical methods to identify significant differences and trends.

  • Literature Review: Compare findings with existing literature to contextualize results.

Advanced Research Questions: Immunogenicity and Vaccine Development

Q: What are the key considerations for investigating the immunogenicity of recombinant Renibacterium salmoninarum elongation factor Tu (tuf) as a potential vaccine candidate?

A: When investigating the immunogenicity of recombinant Renibacterium salmoninarum elongation factor Tu (tuf) for vaccine development:

  • Immunization Protocols: Design immunization protocols to assess immune responses in model organisms.

  • Antibody Titers: Measure antibody titers to evaluate humoral immunity.

  • Cellular Immunity: Assess cellular immune responses using techniques like ELISPOT assays.

  • Challenge Studies: Conduct challenge studies to evaluate vaccine efficacy against Renibacterium salmoninarum infection.

Methodological Considerations for Real-Time PCR

Q: How can researchers optimize real-time PCR conditions for detecting and quantifying Renibacterium salmoninarum DNA, focusing on the tuf gene?

A: Optimizing real-time PCR for detecting Renibacterium salmoninarum DNA involves:

  • Primer Design: Design specific primers targeting the tuf gene.

  • Probe Selection: Use TaqMan probes for specificity and sensitivity.

  • Optimization of Cycling Conditions: Adjust annealing temperatures and cycle numbers to improve specificity and efficiency.

  • Internal Controls: Include internal controls to monitor PCR efficiency and detect potential inhibitors.

Comparative Analysis of Different Detection Methods

Q: What are the advantages and limitations of using real-time PCR versus nested PCR for detecting Renibacterium salmoninarum?

A:

MethodAdvantagesLimitations
Real-time PCRHigh sensitivity, specificity, and speed; quantitative capabilitiesRequires specific equipment and expertise; potential for inhibition
Nested PCRHigh sensitivity; can be more specific with nested primersTime-consuming; risk of contamination; not quantitative

Real-time PCR offers rapid quantification, while nested PCR provides high sensitivity but is more labor-intensive.

Advanced Techniques for Protein Expression and Purification

Q: What advanced techniques can be used to enhance the expression and purification of recombinant Renibacterium salmoninarum elongation factor Tu (tuf)?

A: Advanced techniques for enhancing expression and purification include:

  • Optimization of Expression Conditions: Adjust temperature, pH, and inducer concentration to maximize protein yield.

  • Use of Fusion Tags: Employ fusion tags like His-tag or GST for efficient purification via affinity chromatography.

  • Protein Refolding: Implement refolding protocols if the protein is expressed in inclusion bodies.

Bioinformatics Tools for Sequence Analysis

Q: What bioinformatics tools can be used to analyze the sequence and structure of Renibacterium salmoninarum elongation factor Tu (tuf)?

A: Bioinformatics tools for sequence and structure analysis include:

  • BLAST: For sequence similarity searches.

  • ClustalW: For multiple sequence alignment.

  • SWISS-MODEL: For protein structure prediction.

  • Phyre2: For protein structure prediction and functional site identification.

These tools help in understanding the evolutionary conservation and functional sites of the protein.

Challenges in Studying Recombinant Proteins in Aquatic Pathogens

Q: What are the challenges faced when studying recombinant proteins like elongation factor Tu (tuf) in aquatic pathogens like Renibacterium salmoninarum?

A: Challenges include:

  • Cultivation Difficulty: Renibacterium salmoninarum is fastidious and difficult to culture.

  • Limited Genetic Tools: Few genetic manipulation tools are available for this bacterium.

  • Host-Pathogen Interaction Complexity: Studying host-pathogen interactions requires complex experimental setups.

  • Environmental Factors: Aquatic environments can introduce variability in experimental conditions.

Future Directions in Vaccine Development

Q: What future directions should researchers consider when developing vaccines based on recombinant Renibacterium salmoninarum elongation factor Tu (tuf)?

A: Future directions include:

  • Multivalent Vaccines: Developing vaccines that target multiple antigens.

  • Adjuvant Selection: Identifying optimal adjuvants to enhance immune responses.

  • Delivery Systems: Exploring novel delivery systems, such as nanoparticles or viral vectors.

  • Field Trials: Conducting field trials to assess vaccine efficacy in natural settings.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.